Hajjar E - Search Results

1

Relief in Gastrointestinal Symptoms with Medical Marijuana Over 1 Year.

Wallingford MP, Kelly EL, Herens A, Hanna D, Hajjar E, Worster B. Wallingford MP, et al. Among authors: hajjar e. Med Cannabis Cannabinoids. 2024 Apr 16;7(1):80-85. doi: 10.1159/000538694. eCollection 2024 Jan-Dec. Med Cannabis Cannabinoids. 2024. PMID: 39015606 Free PMC article.

2

Fatty acid metabolism and radiation-induced anti-tumor immunity.

De Martino M, Daviaud C, Hajjar E, Vanpouille-Box C. De Martino M, et al. Among authors: hajjar e. Int Rev Cell Mol Biol. 2023;376:121-141. doi: 10.1016/bs.ircmb.2023.01.003. Epub 2023 Jan 30. Int Rev Cell Mol Biol. 2023. PMID: 36997267 Review.

3

A Longitudinal Observational Study of Medical Cannabis Use and Polypharmacy among Patients Presenting to Dispensaries in Pennsylvania.

Hajjar ER, Herens A, Kelly EL, Madden K, Lungen JM, Worster BK. Hajjar ER, et al. Biomedicines. 2023 Jan 8;11(1):158. doi: 10.3390/biomedicines11010158. Biomedicines. 2023. PMID: 36672666 Free PMC article.

4

Cannabis Use in Patients With Cancer: A Clinical Review.

Worster B, Hajjar ER, Handley N. Worster B, et al. Among authors: hajjar er. JCO Oncol Pract. 2022 Nov;18(11):743-749. doi: 10.1200/OP.22.00080. Epub 2022 Jun 24. JCO Oncol Pract. 2022. PMID: 35749680 Review.

5

Characterizing anxiety, pain, sleep, and quality of life among patients in a state Medical Marijuana Program.

Ashare RL, Kelly E, Hajjar ER, Pant S, Meghani SH, Worster B. Ashare RL, et al. Among authors: hajjar er. Complement Ther Clin Pract. 2022 Aug;48:101612. doi: 10.1016/j.ctcp.2022.101612. Epub 2022 May 31. Complement Ther Clin Pract. 2022. PMID: 35667225

6

Clinician Attitudes, Training, and Beliefs About Cannabis: An Interprofessional Assessment.

Worster B, Ashare RL, Hajjar E, Garber G, Smith K, Kelly EL. Worster B, et al. Among authors: hajjar e. Cannabis Cannabinoid Res. 2023 Jun;8(3):547-556. doi: 10.1089/can.2021.0022. Epub 2021 Dec 31. Cannabis Cannabinoid Res. 2023. PMID: 34978882

7

A Failure to Guide: Patient Experiences within a State-Run Cannabis Program in Pennsylvania, United States.

Reed MK, Kelly EL, Wagner B, Hajjar E, Garber G, Worster B. Reed MK, et al. Among authors: hajjar e. Subst Use Misuse. 2022;57(4):516-521. doi: 10.1080/10826084.2021.2019780. Epub 2021 Dec 27. Subst Use Misuse. 2022. PMID: 34958295

8

Isn't It Time We Stop Counting the Number of Drugs to Define Polypharmacy in This New Era of Deprescribing and What Related Outcomes Should Be Measured?

Hanlon JT, Hajjar ER. Hanlon JT, et al. Among authors: hajjar er. J Am Med Dir Assoc. 2018 Aug;19(8):644-645. doi: 10.1016/j.jamda.2018.04.010. Epub 2018 May 31. J Am Med Dir Assoc. 2018. PMID: 29861195 No abstract available.

9

Polypharmacy in the Geriatric Oncology Population.

Hersh LR, Beldowski K, Hajjar ER. Hersh LR, et al. Among authors: hajjar er. Curr Oncol Rep. 2017 Sep 23;19(11):73. doi: 10.1007/s11912-017-0632-3. Curr Oncol Rep. 2017. PMID: 28942563 Review.

10

Deprescribing: A simple method for reducing polypharmacy.

McGrath K, Hajjar ER, Kumar C, Hwang C, Salzman B. McGrath K, et al. Among authors: hajjar er. J Fam Pract. 2017 Jul;66(7):436-445. J Fam Pract. 2017. PMID: 28700758

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters